FDA Adverse Event Injury Summary report: N

RIVAL PTA BALLOON DILATATION CATHETER

MDR report key: 2221238 · Received August 15, 2011

Report

Report Number
2020394-2011-00187
Event Type
Injury
Date Received
August 15, 2011
Date of Event
June 6, 2011
Report Date
June 6, 2011
Manufacturer
BARD PERIPHERAL VASCULAR, INC.
Product Code
DQY
PMA / PMN Number
K052149
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORDS WERE REVIEWED WITH SPECIAL ATTENTION TO THE RAW MATERIALS, THE SUBASSEMBLIES, THE MANUFACTURING PROCESS AND THE QUALITY CONTROL TESTING. THIS LOT MET ALL RELEASE CRITERIA. THERE IS NOTHING SEEN IN THE DHR TO INDICATE THAT THERE WAS A MANUFACTURING RELATED CAUSE FOR THIS EVENT. THIS IS THE ONLY COMPLAINT REPORTED TO DATE FOR THIS LOT NUMBER. THE DEVICE WAS RETURNED. VISUAL EXAMINATION OF THE BALLOON FOUND A LONGITUDINAL RUPTURE ON THE BARREL OF THE BALLOON, EXTENDING TOWARDS THE DISTAL CONE. IMAGES WERE NOT PROVIDED, THEREFORE, THE REPORTED VESSEL DISSECTION COULD NOT BE CONFIRMED. THE CURRENT IFU (INSTRUCTIONS FOR USE) STATES: WARNINGS: DO NOT EXCEED THE RBP RECOMMENDED FOR THIS DEVICE. BALLOON RUPTURE MAY OCCUR IF THE RBP RATING IS EXCEEDED. TO PREVENT OVER PRESSURIZATION, USE OF A PRESSURE MONITORING DEVICE IS RECOMMENDED. POTENTIAL ADVERSE REACTIONS: VESSEL DISSECTION, PERFORATION, RUPTURE, OR SPASM.

Description of Event or Problem · 1

IT WAS REPORTED THAT AFTER DILATATION OF THE BALLOON TO APPROXIMATELY 8 TO 10 ATMS, THE BALLOON RIPPED, RESULTING IN A VESSEL DISSECTION. REPORTEDLY, EXTRAVASATION WAS OBSERVED IN THE FLUOROSCOPIC IMAGE. THE STENT GRAFT THAT WAS INTENDED TO BE IMPLANTED TO TREAT THE LESION AFTER ANGIOPLASTY WAS ALSO USED TO COVER THE DISSECTION. REPORTEDLY, THE PATIENT IS DOING WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RIVAL PTA BALLOON DILATATION CATHETER DQY BARD PERIPHERAL VASCULAR, INC. GFUL2621

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention